Bright Minds Biosciences Inc. (DRUG:NASDAQ) jumped higher at $2.17, representing a gain of 135.9%. On Thu, Aug 18, 2022, DRUG:NASDAQ touched a New 2-Week High of $2.17. From Thu, Aug 04, 2022, the stock recorded 40.00% Up Days and 54.55% Green Days
The stock spiked on Thu, Aug 18, 2022 at $4.75 with a volume of 119M+.
About Bright Minds Biosciences Inc. (DRUG:NASDAQ)
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain.
Top 10 Gainers:
- Bright Minds Biosciences Inc. (DRUG:NASDAQ), 135.87%
- Plus Therapeutics, Inc. (PSTV:NASDAQ), 53.9%
- Neptune Wellness Solutions Inc. (NEPT:NASDAQ), 49.63%
- Lizhi Inc. (LIZI:NASDAQ), 43.09%
- Endo International plc (ENDP:NASDAQ), 42.9%
- Mind Medicine (MindMed) Inc. (MNMD:NASDAQ), 36.18%
- Indonesia Energy Corporation Limited (INDO:NYSEMKT), 34.02%
- Genius Group Limited (GNS:NYSEMKT), 33.39%
- Wolfspeed Inc. (WOLF:NYSE), 31.86%
- Weber Inc. Class A (WEBR:NYSE), 27.23%